683 Capital Management, LLC Adicet Bio, Inc. Transaction History

683 Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.37 - $17.49 $1.95 Million - $4.63 Million	-265,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $439,727 - $694,196	69,909 Added 35.83%	265,000 $2.08 Million
Q2 2021 Aug 16, 2021	BUY	$9.19 - $15.93 $1.79 Million - $3.11 Million	195,091 New	195,091 $2.01 Million
Q1 2021 May 17, 2021	SELL	$12.12 - $17.17 $312,017 - $442,024	-25,744 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.36 - $14.77 $266,707 - $380,238	25,744 New	25,744 $362,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.